コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 dies that report information on usage of new medical technology.
2 isability in decision-making, and the use of medical technology.
3 he evolving role of financial incentives and medical technology.
4 1 diabetes are a rapidly developing field of medical technology.
5 e of the crucial fields in new generation of medical technology.
6 ny applications ranging from data storage to medical technologies.
7 gnostic technologies differ from therapeutic medical technologies.
8 needs in multiple bioelectronic designs and medical technologies.
9 ares favorably with other currently accepted medical technologies.
10 useful questions about the acceptance of new medical technologies.
11 tions for the clinical translation of future medical technologies.
12 to ensure equitable distribution of COVID-19 medical technologies.
13 es to deploy expensive, infrastructure-heavy medical technologies.
14 lectronic implants that can support emerging medical technologies.
15 ull atropine dose from the Atropen (Meridian Medical Technologies) (0.5 mg) or Mark 1 kits (2 mg), wh
17 considering streamlined authorization of CV medical technologies across selected jurisdictions; deve
18 plasm can arise naturally or result from new medical technologies aimed at preventing mitochondrial g
20 urth, fee-for-service driven use of advanced medical technologies and procedures that beget ICU expan
25 e medical progress involves the evolution of medical technology and the ongoing development of artifi
27 childhood conditions, advances in home-based medical technology, and changes in attitudes about pedia
28 technology, semiconductor-based technology, medical technology, anticorrosion and lubricant technolo
30 risks typically associated with translating medical technologies as they move toward prototypes, pre
31 , we could become global leaders not only in medical technology, as we currently are, but also in hea
32 calculated by using Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psy
33 ssessed using the standardized Institute for Medical Technology Assessment Productivity Cost Question
36 d ratio [AHR], 1.70 [95% CI, 1.43-2.02]) and medical technology assistance (AHR, 2.32 [95% CI, 1.92-2
37 the Proming EDOF Multifocal AM2UX [Eyebright Medical Technology (Beijing) Co., Ltd., China] and the A
38 als and, thus, have the potential to advance medical technology by improving the anchoring performanc
39 (ESLD) is unique in that no widely available medical technology can re-create the life-sustaining fun
40 e use of a Nomag IC 1.5 incubator by Lammers Medical Technology Co., equipped with three coils: an ei
41 data, the Mark 1 autoinjector kit (Meridian Medical Technologies, Columbia, Maryland, USA) appears t
43 ges in treatment algorithms, and advances in medical technology could each influence the applicabilit
45 images were uploaded to the Intelligence in Medical Technologies database directly from the carotid
47 a need to foster an environment conducive to medical technology development and validation so that Eu
49 (FDG) is a relatively recent addition to the medical technology for imaging of cancer, and FDG PET co
52 f in recent years due in part to advances in medical technology, health care options, and population
53 itals Incubating Program, Shanghai HeartCare Medical Technology, HeMo (China) Bioengineering, Sino Me
55 ds that consider the resources consumed by a medical technology in decisions about how best to use th
60 terials can inform their rational design for medical technologies like drug delivery systems and vacc
62 aration of water, materials engineering, and medical technologies, owing to its fascinating physicoch
67 continues to increase due to advancements in medical technology, public health, nutrition, and socioe
70 health services researchers, specialists in medical technologies, representatives of the imaging ind
71 atment (photosensitizer and light) (Miravant Medical Technologies, Santa Barbara, California), photos
72 ted circuitry, optical computing, solar, and medical technologies, setting high expectations for many
73 ogical and Physical Medicine Devices reviews medical technologies that interface with the nervous sys
74 pt of brain death coincided with advances in medical technology that facilitated artificial ventilati
76 h and the advancement of adaptive, practical medical technologies to support and sustain military hea
78 rs believe that the deployment of aggressive medical technology to win the "war" against the pandemic
80 t reviews methods for economic evaluation of medical technologies, with a particular focus on cost-ef